BSEM (BioStem Technologies) Shares Buyback Ratio %: -6.55 (As of Sep. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSEM BioStem Technologies Inc BSEM
37 GF Score
Price $4.01
! 6 Warning Signs
View Full Analysis

What is BioStem Technologies Shares Buyback Ratio %?

BioStem Technologies BSEM -4.41% 37 Shares Buyback Ratio % is -6.55 as of Sep. 15, 2026. GuruFocus rates BSEM with a GF Score™ of 37/100. The stock has 6 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. BioStem Technologies's current shares buyback ratio was -6.55%.


BioStem Technologies Shares Buyback Ratio % Related Terms


BioStem Technologies Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for BioStem Technologies's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioStem Technologies Shares Buyback Ratio % Chart

BioStem Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.75 -5.19 -25.43 -33.38 -2.76

BioStem Technologies Quarterly Data
Jun14 Dec16 Dec17 Dec18 Jun19 Jun20 Dec20 Dec21 Dec22 Dec23 Dec24 Jun25 Jun26
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.16 -23.64 -1.98 -0.09 -5.04
BSEM
37GF Score
BioStem Technologies Inc BSEM
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioStem Technologies Shares Buyback Ratio % Calculation

BioStem Technologies's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(16.214 - 16.643) / 16.214
=-2.65%

BioStem Technologies's Shares Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2025 ) - Shares Outstanding (EOP) (A: Jun. 2026 )) / Shares Outstanding (EOP) (A: Jun. 2025 )
=(16.726 - 17.821) / 16.726
=-6.55%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -6.55 mean?
BioStem Technologies (BSEM) has a Shares Buyback Ratio % of -6.55 as of Sep. 15, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on BioStem Technologies and its competitors.
Is BioStem Technologies' Shares Buyback Ratio % too high?
BioStem Technologies' current Shares Buyback Ratio % is -6.55. Overall, BioStem Technologies has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does BioStem Technologies' Shares Buyback Ratio % compare to IBIO and CSBR?
BioStem Technologies' Shares Buyback Ratio % of -6.55 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Biotechnology company?
A good Shares Buyback Ratio % depends on the Biotechnology industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on BioStem Technologies and its competitors. BioStem Technologies's current Shares Buyback Ratio % is -6.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioStem Technologies stock overvalued right now?
BioStem Technologies (BSEM) has a current Shares Buyback Ratio % of -6.55. The current Shares Buyback Ratio % is -6.55. BioStem Technologies' overall GF Score™ is 37/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For BioStem Technologies (BSEM), the current Shares Buyback Ratio % is -6.55 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioStem Technologies Business Description

Other Exchanges 0JQ:Germany
Address 2836 Center Port Circle, Pompano Beach, FL, USA, 33064
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
37GF Score

Get the complete analysis for BSEM

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.01
Price